Spero Therapeutics (SPRO) Non-Current Assets (2016 - 2026)
Spero Therapeutics (SPRO) recorded Non-Current Assets of $1.18 million in Q2 2026, down 56.5% from $2.72 million a year earlier and down 16.1% from the prior quarter.
Spero Therapeutics (SPRO) Non-Current Assets (2016 - 2026) Analysis & Trends
At the end of FY2025, Spero Therapeutics reported Non-Current Assets of $1.63 million, down 50.0% from FY2024.
- Annual Non-Current Assets has a five-year compound annual growth rate of -35.2% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $3.27 million in FY2024 (-93.6%), $51.18 million in FY2023 (+355.7%), $11.23 million in FY2022 (-14.9%) and $13.2 million in FY2021 (-7.7%).
- The Q2 2026 figure is the lowest quarterly Non-Current Assets in data going back to Q4 2016.
- On a year-over-year basis, Non-Current Assets has declined for eight consecutive quarters, with an average decline of 63.5% over the last eight quarters.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 355.7% in Q4 2023, against a decline of 93.6% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.41 million (Q1 2026), $1.63 million (Q4 2025) and $1.85 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.47 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 159.99 Bn |
| 10 | Spero Therapeutics | 58.73 Mn | -137.06 Mn | - | 1.18 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.18 Mn |
| Mar 31, 2026 | 1.41 Mn |
| Dec 31, 2025 | 1.63 Mn |
| Sep 30, 2025 | 1.85 Mn |
| Jun 30, 2025 | 2.72 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 3.27 Mn |
| Sep 30, 2024 | 3.53 Mn |
| Jun 30, 2024 | 27.66 Mn |
| Mar 31, 2024 | 27.55 Mn |
| Dec 31, 2023 | 51.18 Mn |
| Sep 30, 2023 | 4.88 Mn |
| Jun 30, 2023 | 10.54 Mn |
| Mar 31, 2023 | 10.88 Mn |
| Dec 31, 2022 | 11.23 Mn |
| Sep 30, 2022 | 11.59 Mn |
| Jun 30, 2022 | 11.67 Mn |
| Mar 31, 2022 | 13.13 Mn |
| Dec 31, 2021 | 13.20 Mn |
| Sep 30, 2021 | 12.92 Mn |
Spero Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=SPRO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "SPRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=SPRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();